| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |